Skip to content
Contactez-nous: (+33) 1 64 62 10 12
Theradiag
  • Home
  • Company
    • About us
    • Our history
    • Our management team
    • Know-how
    • Privacy policy
  • Theranostic
    • Therapeutic Drug Monitoring of Biologics
      • When to perform TDM ?
      • Results interpretation
      • Therapeutic Thresholds
      • Tracker Publications
      • Guidelines
      • Frequently asked questions
    • TRACKER
      • LISA TRACKER
      • i-Tracker
      • i-Track 10
      • ez-Track1 & ez-Tracker
      • Immunotrol Tracker
  • Diagnostics
    • Autoimmunity
      • Reagents – Autoimmunity
      • Quality Control – Auto-Immunity
    • Other fields
    • Instrumentation
      • Theralis
      • FIDIS™
  • Services
    • Technical Documentation Download Center
  • News
    • Press Releases
    • List of upcoming events
    • Congress calendar
  • Contacts
  • Français
  • English
Menu Close

Analyst coverage

  1. Home>
  2. Investors>
  3. Shareholder information>
  4. Analyst coverage

Analysts covering Theradiag :

  • SWISSLIFE BioStrategic Research – Lionel Labourdette
  • PORTZAMPARC – Clement Bassat

You can access the latest research notes published (only available in French) :

THERADIAG Flash Portzamparc 12.01.2021

THERADIAG Flash Portzamparc 12.01.2021

THERADIAG Flash Portzamparc 22.07.2020

THERADIAG Flash SwissLife 22.07.2020

THERADIAG Flash SwissLife 23.04.2020

THERADIAG Flash SwissLife 20.03.2020

THERADIAG Flash Portzamparc 31.01.2020

THERADIAG Flash SwissLife 31.01.2020

THERADIAG Flash SwissLife  11.12.2019

THERADIAG Flash SwissLife 25.09.2019

THERADIAG Flash SwissLife 19.07.2019 

THERADIAG Flash Portzamparc 19.07.2019

THERADIAG Flash Portzamparc 02.04.2019

Latest Press Releases

  • 15/12/2023: COMPLETION OF THE THERADIAG MERGER-ABSORPTION BY BIOSYNEX
    15 December 2023/
    0 Comments
  • 11/10/2023: Theradiag reports 20% revenue growth in Q3 2023
    11 October 2023/
    0 Comments
  • 18/09/2023: Theradiag announces its 2023 half-year results and reports a significant improvement in profitability
    18 September 2023/
    0 Comments

Events

No event found!

Next financial Event

No event found!

Useful links

  • Diagnostic
  • Theranostic
  • Events
  • Register to receive our latests news

Contact Information

  • Address:14, Rue Ambroise Croizat, 77183 Croissy Beaubourg, France
  • Phone:+33 1 64 62 10 12
  • Email:info.croissy@biosynex.comOpens in your application

Follow Us

Biosynex - Theradiag ©
  • Home
  • Company
    • About us
    • Our history
    • Our management team
    • Know-how
    • Privacy policy
  • Theranostic
    • Therapeutic Drug Monitoring of Biologics
      • When to perform TDM ?
      • Results interpretation
      • Therapeutic Thresholds
      • Tracker Publications
      • Guidelines
      • Frequently asked questions
    • TRACKER
      • LISA TRACKER
      • i-Tracker
      • i-Track 10
      • ez-Track1 & ez-Tracker
      • Immunotrol Tracker
  • Diagnostics
    • Autoimmunity
      • Reagents – Autoimmunity
      • Quality Control – Auto-Immunity
    • Other fields
    • Instrumentation
      • Theralis
      • FIDIS™
  • Services
    • Technical Documentation Download Center
  • News
    • Press Releases
    • List of upcoming events
    • Congress calendar
  • Contacts
  • Français
  • English